Publications

Articles: 101 · Reviews: 3 · Book chapters: 2 · Preprints: 9 · Conference abstracts: 50. Data: publications.json.

Articles (101)

1. 2026
   SWI/SNF complexes shape 3D chromatin architecture through CTCF and cohesinDebek S, Meydan C, Chin CR, … (20 more), Barisic DNature · DOI 10.1038/s41586-026-11197-wFirst authorCorresponding author
2. 2026
   Systemic elevation of gut derived p-cresol during one year in space: implications for brain, heart, bone, liver and microbiome in astronautsSchmidt MA, Schmidt CM, Schmidt JC, Meydan C, Afshin EE, Overbey EG, Kim J, Singh RS, Beheshti A, Mason CEFrontiers in Physiology · DOI 10.3389/fphys.2026.1878680
3. 2026
   Targeting macrophage ferritin heavy chain mitigates ferroptosis and lung injury in experimental acute respiratory distress syndromeZhang WZ, Kim K, Bhatia D, … (8 more), Meydan C, … (11 more), Cloonan SMNature Communications · DOI 10.1038/s41467-026-74828-w
4. 2026
   Epigenetic regulation of chromosomal instability by EZH2 methyltransferaseBai Y, Agustinus AS, Yomtoubian S, Meydan C, … (16 more), Mittal VCancer Discovery · DOI 10.1158/2159-8290.CD-25-0947
5. 2026
   SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilitiesPelzer B, Meydan C, Spiegel IM, … (44 more), Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-25-1458
6. 2026
   CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaPrajapati SC, Meydan C, Neelamraju Y, … (20 more), Garrett-Bakelman FENeoplasia · DOI 10.1016/j.neo.2026.101293
7. 2026
   The LMO2-LDB1-TAL1 complex regulates transcription networks in acute myeloid leukemiaDunham N, Wang Z, Neelamraju Y, … (2 more), Meydan C, … (26 more), Garrett-Bakelman FEBlood Neoplasia · DOI 10.1016/j.bneo.2025.100186
8. 2025
   Wild-type p53 overexpression in NPM1-mutated acute myeloid leukemia: potential implications for disease biology and therapy responseBarone PD, Dzedzik S, Kleinman AS, Chin CR, Meydan C, Valencia I, Sugita M, Guzman ML, Fein JA, Kaner JD, Desai P, Roboz GJ, Melnick AM, Mason CE, Patel SSHaematologica · DOI 10.3324/haematol.2025.288054
9. 2025
   Global biogeography of airborne viruses in public transit systems and their host interactionsLei H, Du S, Tong X, … (10 more), Meydan C, … (7 more), Lee PKHMicrobiome · DOI 10.1186/s40168-025-02173-z
10. 2025
    The novel immunocompetent Eμ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphomaJafari H, Brown-Burke F, Pray B, … (21 more), Meydan C, … (3 more), Alinari LClinical Cancer Research · DOI 10.1158/1078-0432.CCR-25-0534
11. 2025
    Genomic Analysis of Cardiovascular Diseases Utilizing Space Omics and Medical AtlasLee R, Rayhun A, Kim JK, Meydan C, Beheshti A, Sporn K, Kumar R, Calixte J, McNerney MW, Shah J, Waisberg E, Ong J, Mason CGenes · DOI 10.3390/genes16090996
12. 2025
    CAMP: a modular metagenomics analysis system for integrated multistep data explorationMak L, Tierney B, Wei W, … (24 more), Mangul S, The International MetaSUB Consortium including Meydan CNAR Genomics and Bioinformatics · DOI 10.1093/nargab/lqaf172
13. 2025
    A multi-omic study profiles women with PCOS to reveal unique gut microbiome compositionsLili L, Kunces LJ, Meydan C, Pesce S, Afshin EE, Rickard N, Stujenske TM, D'Adamo CR, Dudley JT, Zhang B, Mason CEPrecision Clinical Medicine · DOI 10.1093/pcmedi/pbaf012
14. 2025
    Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomesSakamoto T, Leca J, Zhang X, Meydan C, … (27 more), Mak TWProceedings of the National Academy of Sciences · DOI 10.1073/pnas.2415779122
15. 2025
    EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell functionIsshiki Y, Chen X, Teater M, … (3 more), Meydan C, … (17 more), Béguelin WCancer Cell · DOI 10.1016/j.ccell.2024.11.006
16. 2024
    Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodesTopper MJ, Guarnieri JW, Haltom JA, … (9 more), Meydan C, … (46 more), Baylin SBProceedings of the National Academy of Sciences · DOI 10.1073/pnas.2401968121
17. 2024
    A Multiomics, Molecular Atlas of Breast Cancer SurvivorsBauer BA, Schmidt CM, Ruddy KJ, Olson JE, Meydan C, Schmidt JC, Smith SY, Couch FJ, Earls JC, Price ND, Dudley JT, Mason CE, Zhang B, Phipps SM, Schmidt MAMetabolites · DOI 10.3390/metabo14070396
18. 2024
    Resistance to PRMT5-targeted therapy in mantle cell lymphomaLong ME, Koirala S, Sloan S, … (14 more), Meydan C, … (5 more), Baiocchi RBlood Advances · DOI 10.1182/bloodadvances.2023010554
19. 2024
    The Space Omics and Medical Atlas (SOMA) and international astronaut biobankOverbey EG, Kim J, Tierney BT, … (104 more), Meydan C, Mason CENature · DOI 10.1038/s41586-024-07639-yCorresponding author
20. 2024
    Molecular and physiological changes in the SpaceX Inspiration4 civilian crewJones CW, Overbey EG, Lacombe J, … (1 more), Meydan C, … (53 more), Mason CENature · DOI 10.1038/s41586-024-07648-x
21. 2024
    Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflightKim J, Tierney BT, Overbey EG, … (7 more), Meydan C, … (38 more), Mason CENature Communications · DOI 10.1038/s41467-024-49211-2
22. 2024
    Longitudinal multi-omics analysis of host microbiome architecture and immune responses during short-term spaceflightTierney BT, Kim J, Overbey EG, … (9 more), Meydan C, … (23 more), Mason CENature Microbiology · DOI 10.1038/s41564-024-01635-8
23. 2024
    Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunctionSiew K, Nestler KA, Nelson C, … (15 more), Meydan C, … (85 more), Walsh SBNature Communications · DOI 10.1038/s41467-024-49212-1
24. 2024
    Single-cell analysis identifies conserved features of immune dysfunction in simulated microgravity and spaceflightWu F, Du H, Overbey E, … (11 more), Meydan C, … (9 more), Winer DANature Communications · DOI 10.1038/s41467-023-42013-y
25. 2024
    Spatial multi-omics of human skin reveals KRAS and inflammatory responses to spaceflightPark J, Overbey EG, Narayanan SA, … (16 more), Meydan C, … (3 more), Mason CENature Communications · DOI 10.1038/s41467-024-48625-2
26. 2024
    Secretome profiling reveals acute changes in oxidative stress, brain homeostasis, and coagulation following short-duration spaceflightHouerbi N, Kim J, Overbey EG, … (6 more), Meydan C, … (28 more), Mason CENature Communications · DOI 10.1038/s41467-024-48841-w
27. 2024
    Telomeric RNA (TERRA) increases in response to spaceflight and high-altitude climbingAl-Turki TM, Maranon DG, Nelson CB, Lewis AM, Luxton JJ, Taylor LE, Altina N, Wu F, Du H, Kim J, Damle N, Overbey E, Meydan C, Grigorev K, Winer DA, Furman D, Mason CE, Bailey SMCommunications Biology · DOI 10.1038/s42003-024-06014-x
28. 2024
    Space radiation damage rescued by inhibition of key spaceflight associated miRNAsMcDonald JT, Kim J, Farmerie L, … (16 more), Meydan C, … (16 more), Beheshti ANature Communications · DOI 10.1038/s41467-024-48920-y
29. 2024
    Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatologyCope H, Elsborg J, Demharter S, … (12 more), Meydan C, … (9 more), Beheshti ACommunications Medicine · DOI 10.1038/s43856-024-00532-9
30. 2024
    Aging and putative frailty biomarkers are altered by spaceflightCamera A, Tabetah M, Castañeda V, … (18 more), Meydan C, … (9 more), Beheshti AScientific Reports · DOI 10.1038/s41598-024-57948-5
31. 2024
    Spatiotemporal expression and control of haemoglobin in spaceBorg J, Loy C, Kim J, … (7 more), Meydan C, … (10 more), Borg JNature Communications · DOI 10.1038/s41467-024-49289-8
32. 2024
    Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironmentLi J, Chin CR, Ying HY, Meydan C, … (19 more), Melnick AMNature Communications · DOI 10.1038/s41467-024-47012-1
33. 2024
    ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesisBarisic D, Chin CR, Meydan C, … (20 more), Melnick ACancer Cell · DOI 10.1016/j.ccell.2024.02.010First author
34. 2024
    SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisionsDeng Q, Lakra P, Gou P, … (1 more), Meydan C, … (23 more), Green MRCancer Cell · DOI 10.1016/j.ccell.2024.02.011
35. 2024
    The importance of personalization in high altitude protocols for hematologic and metabolic benefits in sports: A multi-dimensional N-of-1 case studyLili L, Meydan C, Rickard N, Zhang BHeliyon · DOI 10.1016/j.heliyon.2023.e23159
36. 2023
    Elevated A-to-I RNA editing in COVID-19 infected individualsMerdler-Rabinowicz R, Gorelik D, Park J, Meydan C, Foox J, Karmon M, Roth HS, Cohen-Fultheim R, Shohat-ophir G, Eisenberg E, Ruppin E, Mason CE, Levanon EYNAR Genomics and Bioinformatics · DOI 10.1093/nargab/lqad092
37. 2023
    PRMT5 supports multiple oncogenic pathways in mantle cell lymphomaSloan SL, Brown F, Long M, … (22 more), Meydan C, … (4 more), Alinari LBlood · DOI 10.1182/blood.2022019419
38. 2023
    Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hostsGuarnieri JW, Dybas JM, Fazelinia H, … (14 more), Meydan C, … (32 more), Wallace DCScience Translational Medicine · DOI 10.1126/scitranslmed.abq1533
39. 2023
    An aged/autoimmune B-cell program defines the early transformation of extranodal lymphomasVenturutti L, Rivas MA, Pelzer BW, … (9 more), Meydan C, … (10 more), Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-22-0561
40. 2023
    IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironmentLeca J, Lemonnier F, Meydan C, … (17 more), Mak TWCancer Cell · DOI 10.1016/j.ccell.2023.01.003
41. 2023
    Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cellsFortin J, Chiang MF, Meydan C, … (19 more), Mak TWProceedings of the National Academy of Sciences · DOI 10.1073/pnas.2208176120
42. 2022
    Host transcriptional responses in nasal swabs identify potential SARS-CoV-2 infection in PCR negative patientsSaravia-Butler AM, Schisler JC, Taylor D, Beheshti A, Butler D, Meydan C, Foox J, Hernandez K, Mozsary C, Mason CE, Meller RiScience · DOI 10.1016/j.isci.2022.105310
43. 2022
    BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLXia M, David L, Teater M, Gutierrez J, Wang X, Meydan C, Lytle A, Slack GW, Scott DW, Morin RD, Onder O, Elenitoba-Johnson KSJ, Zamponi N, Cerchietti L, Lu T, Philippar U, Fontan L, Wu H, Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-21-1566
44. 2022
    A Wipe-Based Stool Collection and Preservation Kit for Microbiome Community ProfilingHua H, Meydan C, Afshin EE, Lili LN, D’Adamo CR, Rickard N, Dudley JT, Price ND, Zhang B, Mason CEFrontiers in Immunology · DOI 10.3389/fimmu.2022.889702
45. 2022
    SETD2 haploinsufficiency enhances germinal center-associated AICDA somatic hypermutation to drive B cell lymphomagenesisLeung W, Teater M, Durmaz C, Meydan C, Chivu AG, Chadburn A, Rice EJ, Muley A, Camarillo JM, Arivalagan J, Li Z, Flowers CR, Kelleher NL, Danko CG, Imielinski M, Dave SS, Armstrong SA, Mason CE, Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-21-1514
46. 2022
    Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaBarreyro L, Sampson AM, Ishikawa C, … (10 more), Meydan C, … (20 more), Starczynowski DTScience Translational Medicine · DOI 10.1126/scitranslmed.abb7695
47. 2022
    Betacoronavirus-specific alternate splicingKarlebach G, Aronow B, Baylin SB, Butler D, Foox J, Levy S, Meydan C, Mozsary C, Saravia-Butler AM, Taylor DM, Wurtele E, Mason CE, Beheshti A, Robinson PNGenomics · DOI 10.1016/j.ygeno.2022.110270
48. 2022
    System-wide transcriptome damage and tissue identity loss in COVID-19 patientsPark J, Foox J, Hether T, … (42 more), Meydan C, … (1 more), Mason CECell Reports Medicine · DOI 10.1016/j.xcrm.2022.100522Corresponding author
49. 2022
    Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcriptsAmundarain A, Valcárcel LV, Ordoñez R, Garate L, Miranda E, Cendoya X, Carrasco‐Leon A, Calasanz MJ, Paiva B, Meydan C, Mason CE, Melnick A, Rodriguez‐Otero P, Martín‐Subero JI, San Miguel J, Planes FJ, Prósper F, Agirre XAmerican Journal of Hematology · DOI 10.1002/ajh.26450
50. 2021
    Role of miR-2392 in driving SARS-CoV-2 infectionMcDonald JT, Enguita FJ, Taylor D, … (19 more), Meydan C, … (39 more), Beheshti ACell Reports · DOI 10.1016/j.celrep.2021.109839
51. 2021
    Epigenetic Forensics for Suspect Identification and Age PredictionFoox J, Bezdan D, Vijay P, Getz K, Ratanachai K, Davis JW, Booher K, Yang X, Meydan C, Mason CEForensic Genomics · DOI 10.1089/forensic.2021.0005Corresponding author
52. 2021
    Haplotype diversity and sequence heterogeneity of human telomeresGrigorev K, Foox J, Bezdan D, Butler D, Luxton JJ, Reed J, McKenna MJ, Taylor L, George KA, Meydan C, Bailey SM, Mason CEGenome Research · DOI 10.1101/gr.274639.120
53. 2021
    Global Genetic Cartography of Urban Metagenomes and Anti-Microbial ResistanceDanko D, Bezdan D, Afshin EE, … (60 more), Meydan C, … (34 more), Mason CE, The International MetaSUB ConsortiumCell · DOI 10.1016/j.cell.2021.05.002
54. 2021
    The spatial landscape of lung pathology during COVID-19 progressionRendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, Park J, Foox J, Hether T, Warren S, Kim Y, Reeves J, Salvatore S, Mason CE, Swanson EC, Borczuk AC, Elemento O, Schwartz RENature · DOI 10.1038/s41586-021-03475-6
55. 2021
    Shotgun Transcriptome, Isothermal, and Spatial Omics Profiling of SARS-CoV-2 InfectionButler D, Mozsary C, Meydan C, … (75 more), Mason CENature Communications · DOI 10.1038/s41467-021-21361-7First author
56. 2021
    Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myelomaCarrasco-Leon A, Ezponda T, Meydan C, … (23 more), Agirre XLeukemia · DOI 10.1038/s41375-021-01147-y
57. 2021
    A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and bloodNg DL, Granados AC, Santos YA, … (2 more), Meydan C, … (25 more), Chiu CYScience Advances · DOI 10.1126/sciadv.abe5984
58. 2021
    Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrenceDuy C, Li M, Teater M, Meydan C, Garrett-Bakelman FE, Lee TC, Chin CR, Durmaz C, Kawabata KC, Dhimolea E, Mitsiades CS, Doehner H, D'Andrea RJ, Becker MW, Paietta EM, Mason CE, Carroll M, Melnick AMCancer Discovery · DOI 10.1158/2159-8290.cd-20-1375
59. 2021
    Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformationRivas MA, Meydan C, Chin CR, … (17 more), Melnick AMNature Immunology · DOI 10.1038/s41590-020-00827-8
60. 2020
    H1 histones control the epigenetic landscape by local chromatin compactionWillcockson MA, Healton SE, Weiss CN, … (13 more), Meydan C, … (8 more), Skoultchi AINature · DOI 10.1038/s41586-020-3032-z
61. 2020
    Evolution of the epigenetic landscape in childhood B acute lymphoblastic leukemia and its role in drug resistanceSaint Fleur-Lominy S, Evensen NA, Bhatla T, Sethia G, Narang S, Choi JH, Ma X, Yang JJ, Kelly S, Raetz E, Harvey RC, Willman C, Loh ML, Hunger SP, Brown PA, Getz KM, Meydan C, Mason CE, Tsirigos A, Carroll WLCancer Research · DOI 10.1158/0008-5472.CAN-20-1145
62. 2020
    Somatic mutations drive specific but reversible epigenetic heterogeneity states in AMLLi S, Chen X, Wang J, Meydan C, Glass JL, Shih AH, Delwel R, Levine RL, Mason CE, Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-19-0897
63. 2020
    Multi-omic, single-cell, and biochemical profiles of astronauts guide pharmacological strategies for returning to gravityGertz ML, Chin CR, Tomoiaga D, MacKay M, Chang C, Butler D, Afshinnekoo E, Bezdan D, Schmidt MA, Mozsary C, Melnick A, Garrett-Bakelman F, Crucian B, Lee SMC, Zwart SR, Smith SM, Meydan C, Mason CECell Reports · DOI 10.1016/j.celrep.2020.108429
64. 2020
    Telomere Length Dynamics and DNA Damage Responses Associated with Long-Duration SpaceflightLuxton JJ, McKenna MJ, Lewis A, Taylor LE, George KA, Dixit SM, Moniz M, Benegas W, Mackay MJ, Mozsary C, Butler D, Bezdan D, Meydan C, Crucian BE, Zwart SR, Smith SM, Mason CE, Bailey SMCell Reports · DOI 10.1016/j.celrep.2020.108457
65. 2020
    Temporal Telomere and DNA Damage Responses in the Space Radiation EnvironmentLuxton JJ, McKenna MJ, Taylor LE, George KA, Zwart SR, Crucian BE, Drel VR, Garrett-Bakelman FE, Mackay MJ, Butler D, Foox J, Grigorev K, Bezdan D, Meydan C, Smith SM, Sharma K, Mason CE, Bailey SMCell Reports · DOI 10.1016/j.celrep.2020.108435
66. 2020
    Clonal hematopoiesis before, during, and after human spaceflightMencia-Trinchant N, MacKay MJ, Chin C, Afshinnekoo E, Foox J, Meydan C, Butler D, Mozsary C, Vernice NA, Darby C, Schatz MC, Bailey SM, Melnick AM, Guzman ML, Bolton K, Braunstein LZ, Garrett-Bakelman F, Levine RL, Hassane DC, Mason CECell Reports · DOI 10.1016/j.celrep.2020.108458
67. 2020
    Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure DevelopmentMalkani S, Chin CR, Cekanaviciute E, … (14 more), Meydan C, … (16 more), Beheshti ACell Reports · DOI 10.1016/j.celrep.2020.108448
68. 2020
    Cell-free DNA (cfDNA) and exosome profiling from a year-long human spaceflight reveals circulating biomarkersBezdan D, Grigorev K, Meydan C, … (27 more), Mason CEiScience · DOI 10.1016/j.isci.2020.101844
69. 2020
    Comprehensive Multi-Omics Analysis Reveals Mitochondrial Stress as a Central Hub for Spaceflight Biological Impactda Silveira WA, Fazelinia H, Rosenthal SB, … (2 more), Meydan C, … (31 more), Beheshti ACell · DOI 10.1016/j.cell.2020.11.002First author
70. 2020
    Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaOrdoñez R, Kulis M, Russiñol N, … (6 more), Meydan C, … (28 more), Martin-Subero JIGenome Research · DOI 10.1101/gr.265520.120
71. 2020
    Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infectionRamlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, Tatonetti NP, Shapira SDNature Medicine · DOI 10.1038/s41591-020-1021-2
72. 2020
    Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19Bell LCK, Meydan C, Kim J, Foox J, Butler D, Mason CE, Shapira SD, Noursadeghi M, Pollara GiScience · DOI 10.1016/j.isci.2020.101896
73. 2020
    BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cellsKawabata KC, Zong H, Meydan C, Wyman S, Wouters BJ, Sugita M, Goswami S, Albert M, Yip W, Roboz GJ, Chen Z, Delwel R, Carroll M, Mason CE, Melnick A, Guzman MLBlood · DOI 10.1182/blood.2019001745
74. 2020
    Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune ResponseBéguelin W, Teater M, Meydan C, Hoehn KB, Phillip JM, Soshnev AA, Venturutti L, Rivas MA, Calvo-Fernández MT, Gutierrez J, Camarillo JM, Takata K, Tarte K, Kelleher NL, Steidl C, Mason CE, Elemento O, Allis CD, Kleinstein SH, Melnick AMCancer Cell · DOI 10.1016/j.ccell.2020.04.004
75. 2020
    Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventionsMeydan C, Afshinnekoo E, Rickard N, Daniels G, Kunces L, Hardy T, Lili L, Pesce S, Jacobson P, Mason CE, Dudley J, Zhang BPrecision Clinical Medicine · DOI 10.1093/pcmedi/pbaa013First author
76. 2020
    The Effect of One Year in Space on Long-Chain Fatty Acid Desaturases and ElongasesSchmidt MA, Meydan C, Schmidt CM, Afshinnekoo E, Mason CELifestyle Genomics · DOI 10.1159/000506769
77. 2019
    Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AMLDuy C, Teater M, Garrett-Bakelman FE, … (1 more), Meydan C, … (17 more), Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-19-0106
78. 2019
    Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisHatzi K, Geng H, Doane AS, Meydan C, LaRiviere R, Cardenas M, Duy C, Shen H, Vidal MNC, Baslan T, Mohammad HP, Kruger RG, Shaknovich R, Haberman AM, Inghirami G, Lowe SW, Melnick AMNature Immunology · DOI 10.1038/s41590-018-0273-1
79. 2019
    Growth Kinetics, Carbon Isotope Fractionation, and Gene Expression in the Hyperthermophile Methanocaldococcus jannaschii during Hydrogen-Limited Growth and Interspecies Hydrogen TransferTopçuoğlu BD, Meydan C, Nguyen TB, Lang SQ, Holden JFApplied and Environmental Microbiology · DOI 10.1128/AEM.00180-19
80. 2019
    The NASA Twins Study: A multidimensional analysis of a year-long human spaceflightGarrett-Bakelman FE, Darshi M, Green SJ, … (4 more), Meydan C, … (73 more), Turek FWScience · DOI 10.1126/science.aau8650First author
81. 2019
    Long non-coding RNAs discriminate the stages and gene regulatory states of human humoral immune responseAgirre X, Meydan C, Jiang Y, Garate L, Doane AS, Li Z, Verma A, Paiva B, Martín-Subero JI, Elemento O, Mason CE, Prosper F, Melnick ANature Communications · DOI 10.1038/s41467-019-08679-zFirst author
82. 2018
    Formate hydrogenlyase and formate secretion ameliorate H2 inhibition in the hyperthermophilic archaeon Thermococcus paralvinellaeTopçuoğlu BD, Meydan C, Orellana R, Holden JFEnvironmental Microbiology · DOI 10.1111/1462-2920.14022
83. 2018
    ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2Jain D, Puno MR, Meydan C, Lailler N, Mason CE, Lima CD, Anderson KV, Keeney SeLife · DOI 10.7554/eLife.30919
84. 2018
    Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivityKunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, Maher R, Pronier E, Meyer SC, Garrett-Bakelman FE, Tallman M, Melnick A, Levine RL, Shih AHCancer Cell · DOI 10.1016/j.ccell.2017.11.012
85. 2017
    rahu is a mutant allele of Dnmt3c, encoding a DNA methyltransferase homolog required for meiosis and transposon repression in the mouse male germlineJain D, Meydan C, Lange J, Claeys Bouuaert C, Lailler N, Mason CE, Anderson KV, Keeney SPLoS Genetics · DOI 10.1371/journal.pgen.1006964
86. 2017
    Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiersGlass JL, Hassane D, Wouters BJ, … (7 more), Meydan C, … (10 more), Figueroa MECancer Discovery · DOI 10.1158/2159-8290.CD-16-1032
87. 2017
    Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemiaShih AH, Meydan C, Shank K, Garrett-Bakelman FE, Ward PS, Intlekofer AM, Nazir A, Stein EM, Knapp K, Glass J, Travins J, Straley K, Gliser C, Mason CE, Yen K, Thompson CB, Melnick A, Levine RLCancer Discovery · DOI 10.1158/2159-8290.CD-16-1049First author
88. 2017
    Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cellsVu LP, Prieto C, Amin EM, … (13 more), Meydan C, … (25 more), Kharas MGNature Genetics · DOI 10.1038/ng.3854
89. 2017
    Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cellsKunimoto H, McKenney AS, Meydan C, Shank K, Nazir A, Rapaport F, Durham B, Garrett-Bakelman FE, Pronier E, Shih AH, Melnick A, Chaudhuri J, Levine RLBlood · DOI 10.1182/blood-2016-06-721977
90. 2017
    CREBBP inactivation promotes the development of HDAC3-dependent lymphomasJiang Y, Ortega-Molina A, Geng H, … (8 more), Meydan C, … (18 more), Melnick AMCancer Discovery · DOI 10.1158/2159-8290.CD-16-0975
91. 2016
    The metagenomics and metadesign of the subways and urban biomes (MetaSUB) international consortium inaugural meeting reportThe MetaSUB International Consortium, including Meydan CMicrobiome · DOI 10.1186/s40168-016-0168-z
92. 2015
    Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisViny AD, Ott CJ, Spitzer B, Rivas M, Meydan C, Papalexi E, Yelin D, Shank K, Reyes J, Chiu A, Romin Y, Boyko V, Thota S, Maciejewski JP, Melnick A, Bradner JE, Levine RLJournal of Experimental Medicine · DOI 10.1084/jem.20151317
93. 2015
    Modern Methods for Delineating Metagenomic ComplexityAfshinnekoo E, Meydan C, Chowdhury S, … (42 more), Mason CECell Systems · DOI 10.1016/j.cels.2015.07.007First author
94. 2015
    Geospatial Resolution of Human and Bacterial Diversity with City-Scale MetagenomicsAfshinnekoo E, Meydan C, Chowdhury S, … (42 more), Mason CECell Systems · DOI 10.1016/j.cels.2015.01.001First author
95. 2015
    Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptomeLinder B, Grozhik AV, Olarerin-George AO, Meydan C, Mason CE, Jaffrey SRNature Methods · DOI 10.1038/nmeth.3453
96. 2015
    Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid LeukemiaShih AH, Jiang Y, Meydan C, … (24 more), Levine RLCancer Cell · DOI 10.1016/j.ccell.2015.03.009
97. 2014
    An integrative computational approach for prioritization of genomic variantsDubchak I, Balasubramanian S, Wang S, Meydan C, Sulakhe D, Poliakov A, Börnigen D, Xie B, Taylor A, Ma J, Paciorkowski AR, Mirzaa GM, Dave P, Agam G, Xu J, Al-Gazali L, Mason CE, Ross ME, Maltsev N, Gilliam TCPLoS One · DOI 10.1371/journal.pone.0114903
98. 2014
    Target-independent prediction of drug synergies using only drug lipophilicityYilancioglu K, Weinstein ZB, Meydan C, Akhmetov A, Toprak I, Durmaz A, Iossifov I, Kazan H, Roth FP, Cokol MJournal of Chemical Information and Modeling · DOI 10.1021/ci500276x
99. 2013
    Constructing robust phylogenetic trees for Galanthus L. using the relative complexity measureBakış Y, Otu HH, Taşçı N, Meydan C, Bilgin N, Yüzbaşıoğlu S, Sezerman OUBMC Bioinformatics · DOI 10.1186/1471-2105-14-20
100. 2013
     Prediction of peptides binding to MHC class I and II alleles by temporal motif miningMeydan C, Otu HH, Sezerman OUBMC Bioinformatics · DOI 10.1186/1471-2105-14-S2-S13First author
101. 2010
     Biomarker discovery for toxicityMeydan C, Uğur Sezerman ONeurocomputing · DOI 10.1016/j.neucom.2010.05.009First author

Reviews (3)

1. 2024
   A second space age spanning omics, platforms and medicine across orbitsMason CE, Green J, Adamopoulos KI, … (46 more), Meydan C, … (33 more), Beheshti ANature · DOI 10.1038/s41586-024-07586-8
2. 2020
   Fundamental Biological Features of Spaceflight: Advancing the Field to Enable Deep Space ExplorationAfshinnekoo E, Scott RT, MacKay MJ, … (16 more), Meydan C, … (17 more), Beheshti ACell · DOI 10.1016/j.cell.2020.10.050
3. 2020
   Long term spaceflight and the cardiovascular systemVernice NA, Meydan C, Afshinnekoo E, Mason CEPrecision Clinical Medicine · DOI 10.1093/pcmedi/pbaa022

Book chapters (2)

1. 2025
   Telomere length dynamics associated with short-duration human spaceflightShirah B, Overbey EG, Foox J, … (4 more), Meydan C, … (16 more), Mason CENeuroscience Research in Short-Duration Human Spaceflight · DOI 10.1016/b978-0-443-33918-9.00003-1
2. 2025
   Surrogate assessment of brain health using longitudinal measures of blood-based biomarkers in short-duration human spaceflightShirah B, zu Eulenburg P, Overbey EG, … (6 more), Meydan C, … (21 more), Mason CENeuroscience Research in Short-Duration Human Spaceflight · DOI 10.1016/b978-0-443-33918-9.00007-9

Preprints (9)

1. 2026
   Targeted deletion of macrophage ferritin heavy chain protects from macrophage ferroptosis in acute respiratory distress syndromeZhang W, Kim K, Faherty L, Simmons W, Carrasco S, Hoffman K, Houghton S, Hsu CL, Haber L, Goyal P, Chung KP, Ballman K, Redmond D, Mancias J, Choi A, Schenck E, Plataki M, Mason C, Meydan C, Cloonan SResearch Square · DOI 10.21203/rs.3.rs-5276478/v1
2. 2026
   Diverse High-Fat Diets Drive Multi-Omic Reprogramming that Persists after Dietary ReversalVan Camp AG, Park J, Ozcelik E, … (23 more), Meydan C, … (1 more), Beyaz SSSRN · DOI 10.2139/ssrn.6690547Corresponding author
3. 2025
   Guardians of the Mitochondria: Space Mitochondria 2.0 Systemic Analysis Reveals Bioenergetic Dysregulation Across SpeciesGuarnieri JW, Maghsoudi Z, Kim J, … (34 more), Meydan C, … (10 more), Beheshti ASSRN · DOI 10.2139/ssrn.5087025
4. 2023
   Viral activation and ecological restructuring characterize a microbiome axis of spaceflight-associated immune activationMason C, Tierney B, Kim J, … (10 more), Meydan C, … (22 more), Church GResearch Square · DOI 10.21203/rs.3.rs-2493867/v1
5. 2023
   More than a feeling: dermatological changes impacted by spaceflightCope H, Elsborg J, Demharter S, … (11 more), Meydan C, … (8 more), Beheshti AResearch Square · DOI 10.21203/rs.3.rs-2367727/v1
6. 2021
   Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue MapsPark J, Foox J, Hether T, … (41 more), Meydan C, … (1 more), Mason CEbioRxiv · DOI 10.1101/2021.03.08.434433
7. 2021
   A Molecular Basis of Long COVID-19Frere JJ, Serafini RA, Pryce KD, … (13 more), Meydan C, … (3 more), tenOever BRSSRN · DOI 10.2139/ssrn.3885245
8. 2020
   Multi-omics Analysis of Dsup Expressing Human Cells Reveals Open Chromatin Architectural DifferencesWestover C, Najjar D, Meydan C, Grigorev K, Veling MT, Chang RL, Chin C, Butler D, Afshin EE, Silver PA, Mason CEbioRxiv · DOI 10.1101/2020.11.10.373571
9. 2015
   Building genomic analysis pipelines in a hackathon setting with bioinformatician teams: DNA-seq, epigenomics, metagenomics and RNA-seqBusby B, Dillman A, Simpson CL, … (28 more), Yaschenko EbioRxiv · DOI 10.1101/018085

Conference abstracts (50)

1. 2026
   Causal Decoding of Spaceflight Cellular Responses via CRISPR Perturb-seq, Secretome Profiling, and Model Organism StudiesKim J, Caragine C, Willett J, Hirschberg J, Borg J, Collier P, Overbey E, Saygili E, Proszynski J, Meydan C, Walsh K, Sanjana N, Plummer J, Martelotto L, Beheshti A, Borg J, Mason C46th COSPAR Scientific Assembly
2. 2026
   PRMT5 inhibition alters cellular chromatin landscape and drives vulnerability to BH3 mimetics in mantle cell lymphomaWeigel C, Hinterschied C, Koirala S, … (14 more), Meydan C, … (8 more), Baiocchi RCancer Research · DOI 10.1158/1538-7445.am2026-4490
3. 2025
   Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilitiesPelzer B, Meydan C, Spiegel I, … (42 more), Melnick ABlood · DOI 10.1182/blood-2025-140
4. 2025
   Proteomic, epigenomic, genomic, and immunological changes induced by spaceflightsKim J, Overbey E, Hirschberg J, … (4 more), Meydan C, … (18 more), Mason CEuropean Journal of Human Genetics
5. 2024
   The LMO2-LDB1-TAL1 Complex Regulates Transcription Networks in AML RelapseDunham N, Wang Z, Neelamraju Y, … (3 more), Meydan C, … (18 more), Garrett-Bakelman FEBlood · DOI 10.1182/blood-2024-200289
6. 2024
   Integrative multi-omic analysis of astronauts from NASA Twins, Inspiration4, Axiom-2, and Polaris Dawn missionsKim J, Mason C, Overbey E, Tierney B, Meydan C, Ryon K, Najjar D, Rosenberg M, Mateus J45th COSPAR Scientific Assembly
7. 2024
   Comprehensive and Integrative Single Cell Multiomics Analysis of the Immune System of Private Mission AstronautsKim J, Mason C, Overbey E, Tierney B, Najjar D, Ryon K, Meydan C, Mateus J, Rosenberg MEuropean Journal of Human Genetics
8. 2024
   ARID1A mutations shape memory B-cell dynamics and confer sensitivity to SWI/SNF remodeling complex inhibition in lymphomaBarisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, Steidl C, Scott DW, Weng AP, Green MR, Melnick ABlood Cancer Discovery · DOI 10.1158/2643-3249.bcdsymp24-p11
9. 2023
   SWI/SNF Chromatin Remodeling Complex Orchestrates Sequential Binding of Key Transcription Factors in B Cells and Restricts Aggressive LymphomaBarisic D, Chin C, Meydan C, Teater M, Tsialta I, Mlynarczyk C, Chadburn A, Xia M, Steidl C, Scott DW, P. Weng A, Mason C, Green MR, Melnick AMBlood · DOI 10.1182/blood-2023-190494
10. 2023
    Cooperative Super-Enhancer Inactivation through Loss of Crebbp and KMT2D Skews B Cell Fate Decisions and Yields T Cell-Depleted LymphomasLi J, Chin C, Ying HY, Meydan C, Teater M, Xia M, Farinha P, Takata K, Chu CS, Rivas MA, Chadburn A, Steidl C, Scott DW, Roeder RG, Mason C, Béguelin W, Melnick AMBlood · DOI 10.1182/blood-2023-174501
11. 2023
    Loss of CCAAT-Enhancer Binding Protein Delta Promotes Acute Myeloid Leukemia Cell Proliferation and Survival By Upregulating Cyclin D1 ExpressionPrajapati S, Meydan C, Dillon R, … (17 more), Garrett-Bakelman FEBlood · DOI 10.1182/blood-2023-181946
12. 2023
    Developing next-generation drug sensitivity screening using primary tumor specimensKawabata K, Wouters B, Meydan C, Melnick A, Nannya Y, Takahashi SExperimental Hematology
13. 2023
    Abstract A16: Multi-omic analyses in genetically engineered mice reveal distinct and overlapping effects of leukemogenic Idh and Tet2 mutationsFortin J, Chiang MF, Meydan C, … (19 more), Mak TBlood Cancer Discovery
14. 2023
    Genomic and phenotypic predictors of human ex vivo sensitivity to simulated deep space radiationCekanaviciute E, Pasternak C, Sanders L, Meydan C, Foox J, Verma S, Pariset E, Juran C, Boyko V, Malkani S, Lopez-Macha A, Lima I, Mason C, Costes SNASA Human Research Program Investigators Workshop
15. 2023
    Gene expression profiles reveal distinct regulatory activities of transcription factors GATA1 and TAL1 upon AML relapseWang Z, Neelamraju Y, Meydan C, … (18 more), Garrett-Bakelman FECancer Research · DOI 10.1158/1538-7445.am2023-3155
16. 2022
    Smarca4 (Brg1) Controls Germinal Center B-Cell Development and Is a Haploinsufficient Tumor Suppressor in B Cell LymphomaDeng Q, Meydan C, Lakra P, Barisic D, Chin CR, Rojas-Neira E, Ravanmehr V, Henderson J, Gou P, El-Mallawany NK, Allen C, Cuglievan B, Vega F, Mason CE, Melnick A, Green MRBlood · DOI 10.1182/blood-2022-166258
17. 2022
    Acquired Resistance to PRMT5 Inhibition in Mantle Cell Lymphoma Is Associated with Compensatory Pathway ActivationLong M, Koirala S, Sloan S, Brown F, Tallada S, Hinterschied C, Corps K, Helmig-Mason J, Chung J, Scherle P, Vaddi K, Meydan C, Foox J, Butler D, Mason C, Alinari L, Blaser B, Baiocchi RBlood
18. 2022
    Epigenetic control of tumor cell killing by natural killer cellsPasion J, Barisic D, Meydan C, Ng KY, Lafoz MT, Huse M, Melnick A, Wendel HGCancer Research · DOI 10.1158/1538-7445.am2022-3731
19. 2021
    PRMT5 inhibition modulates E2F1 and P53 to restore cell cycle regulation and drive DNA damage response in ibrutinib-resistant mantle cell lymphomaSloan S, Brown F, Long M, … (6 more), Meydan C, … (10 more), Alinari LBlood · DOI 10.1182/blood-2021-153992
20. 2020
    Chemotherapy induces a transient senescence-like state capable of initiating AML recurrenceLi M, Teater M, Meydan C, Garrett-Bakelman FE, Chin C, Carroll M, Melnick A, Duy CCancer Research · DOI 10.1158/1538-7445.am2020-651
21. 2020
    Lung Injury Due to COVID-19 Relative to Influenza and Nonviral ARDS and Normal ControlsBorczuk A, Kim Y, Hether T, Meydan C, Foox J, Bram Y, Salvatore S, Bailey M, Danaher P, White A, Reeves J, Warren S, Beechem J, Mason C, Schwartz RJournal of Molecular Diagnostics
22. 2020
    Clinical relevance of lncRNAs involved in fusion transcripts expressed in multiple myelomaAmundarain A, Valcarcel L, Ordonez R, Garate L, Miranda E, Cendoya X, Carrasco-Leon A, Calasanz M, Paiva B, Meydan C, Mason C, Melnick A, Rodriguez-Otero P, Miguel J, Planes F, Prosper F, Agirre XHaematologica
23. 2020
    Circulating miRNA Spaceflight Signature Reveals Targets to Mitigate Associated Health RisksMalkani S, Chin C, Cekanaviciute E, … (14 more), Meydan C, … (14 more), Beheshti AHuman Research Program Investigators Workshop
24. 2019
    Ezh2 gain-of-function mutations generate a lymphoma-permissive immune nicheBéguelin W, Teater MR, Meydan C, Phillip JM, Melnick ABlood · DOI 10.1182/blood-2019-132263
25. 2019
    Characterization of Complete Lncrnas Transcriptome Reveals Expression of Lncrnas As a Prognostic Factor and Linc-Smilo As a Potential Therapeutic Target in Multiple MyelomaCarrasco A, Ezponda T, Meydan C, … (22 more), Agirre XBlood · DOI 10.1182/blood-2019-123008
26. 2019
    Computational Systems Biology Models for the Identification of Metabolic Vulnerabilities in Multiple MyelomaValcárcel LVV, Ordoñez R, Apaolaza I, Valcárcel A, Garate L, Meydan C, Paiva B, Melnick AM, San-Miguel J, Planes FJ, Agirre X, Prosper FBlood · DOI 10.1182/blood-2019-123970
27. 2019
    Role of lncRNAs as prognostic factor and potential therapeutic target in Multiple MyelomaCarrasco-Leon A, Ezponda T, Meydan C, … (22 more), Prosper FClinical Lymphoma, Myeloma & Leukemia · DOI 10.1016/j.clml.2019.09.585
28. 2019
    Analysis of the complexity and heterogeneity of the lncRNAs transcriptome and its relevance in multiple myelomaCarrasco-Leon A, Ezponda T, Meydan C, Valcarcel L, Ordonez R, Kulis M, Garate L, Miranda E, Segura V, Guruceaga E, Vilas-Zornoza A, Alignani D, Castro-Labrador L, Pascual M, Paiva B, Miguel J, Martin-Subero J, Melnick A, Prosper F, Agirre XHaematologica
29. 2019
    PF583 Comprehensive analysis of the complexity and heterogeneity of the lncRNAs transcriptome in multiple myelomaCarrasco‐Leon A, Ezponda T, Meydan C, … (21 more), Agirre XHemaSphere · DOI 10.1097/01.hs9.0000560620.31894.f0
30. 2019
    PF567 Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myelomaOrdoñez R, Kulis M, Russiñol N, … (2 more), Meydan C, … (23 more), Prósper FHemaSphere · DOI 10.1097/01.hs9.0000560560.72691.d3
31. 2018
    Therapeutic Targeting of the Ubiquitin Conjugating Enzyme UBE2N in Myeloid MalignanciesBarreyro L, Sampson A, Hueneman K, … (12 more), Meydan C, … (11 more), Starczynowski DTBlood · DOI 10.1182/blood-2018-99-115359
32. 2018
    Growth Kinetics and Gene Expression in a Hyperthermophilic Methanogen during H2-limited and Syntrophic GrowthTopcuoglu B, Meydan C, Holden JGoldschmidt Conference
33. 2017
    SOX9 enhancer regulator may play an oncogenic role in B-cell lymphomasFachel AA, Jiang Y, Tam W, Muley AS, Meydan C, Agirre X, Melnick AM, Richards KLClinical Cancer Research · DOI 10.1158/1557-3265.hemmal17-30
34. 2017
    Genetically-defined AML subgroups represent diverse epigenetic heterogeneity landscapeLi S, Chen X, Wang J, Meydan C, Glass J, Shih A, Valk P, Delwel R, Levine R, Mason C, Melnick ABlood
35. 2017
    Heterogeneity of the expression of long non-coding RNAs and their functional implication in multiple myelomaCarrasco A, Ezponda T, Meydan C, Kulis M, Ordonez R, Segura V, Garate L, Alignani D, Paiva B, Miguel J, Subero J, Melnick A, Agirre X, Prosper FHaematologica
36. 2017
    Definition of the reference epigenoma and identification of new epi-oncogenes in multiple myelomaOrdonez R, Kulis M, Russinol N, Beekman R, Meydan C, Dot N, Carrasco A, Ezponda T, Martens J, Stunnenberg H, Paiva B, Miguel J, Melnick A, Campo E, Agirre X, Subero J, Prosper FHaematologica
37. 2017
    Long non-coding RNAs expression heterogeneity and functional involvement in multiple myelomaCarrasco A, Ezponda T, Meydan C, Kulis M, Ordonez R, Segura V, Garate L, Alignani D, Paiva B, Miguel J, Martin-Subero J, Melnick A, Prosper F, Agirre XHaematologica
38. 2017
    Multilayer epigenomic analyses reveal of new candidate oncogenes involved in the pathogenesis of multiple myelomaOrdonez R, Kulis M, Russinol N, Beekman R, Meydan C, Verdaguer-Dot N, Carrasco A, Ezponda T, Martens J, Stunnenberg H, Paiva B, Miguel J, Melnick A, Campo E, Prosper F, Agirre X, Martin-Subero JHaematologica
39. 2016
    Targeting Beta-Catenin Signaling in DLBCL with ICG-001 and PAM-1 Suppresses Cell Proliferation and Induces ApoptosisFachel AA, Muley AS, Meydan C, Agirre X, Cerchietti L, Melnick A, Richards KLBlood · DOI 10.1182/blood.v128.22.5382.5382
40. 2016
    Long Non-Coding RNAs Annotation and Their Involvement in Multiple MyelomaCarrasco A, Ezponda T, Meydan C, Kulis M, Ordoñez R, Garate L, Segura V, Alignani D, Paiva B, San Miguel J, Martin Subero JI, Melnick A, Prosper F, Agirre XBlood · DOI 10.1182/blood.v128.22.4420.4420
41. 2016
    Cooperative Gene Repression By DNA Methylation and LSD1-Mediated Enhancer Inactivation in Acute Myeloid LeukemiaDuy C, Teater M, Garrett-Bakelman FE, Lee TC, Meydan C, Glass JL, Li M, Mohammad H, Smitheman K, Shih AH, Abdel-Wahab O, Paietta E, Tallman MS, Guzman ML, Kruger RG, Creasy CL, Levine RL, Carroll M, Melnick ABlood · DOI 10.1182/blood.v128.22.1048.1048
42. 2015
    Dose-Dependent Role of the Cohesin Complex in Normal and Malignant HematopoiesisViny AD, Ott CJ, Spitzer B, Rivas MA, Meydan C, Papalexi E, Yelin D, Shank K, Reyes J, Chiu A, Thota S, Maciejewski JP, Melnick A, Bradner JE, Levine RLBlood · DOI 10.1182/blood.v126.23.435.435
43. 2015
    Significance of Novel Gene Mutations in AMLShih A, Jiang Y, Meydan C, Melnick A, Levine RAnnals of Hematology
44. 2014
    AG-221, a Small Molecule Mutant IDH2 Inhibitor, Remodels the Epigenetic State of IDH2-Mutant Cells and Induces Alterations in Self-Renewal/Differentiation in IDH2-Mutant AMLShih AH, Shank KR, Meydan C, Intlekofer AM, Ward P, Thompson CB, Melnick AM, Travins J, Straley K, Gliser C, Yen K, Levine RLBlood · DOI 10.1182/blood.v124.21.437.437
45. 2012
    Representation of protein secondary structure using bond-orientational order parametersMeydan C, Sezerman OUPattern Recognition in Bioinformatics (PRIB) · DOI 10.1007/978-3-642-34123-6_17First author
46. 2011
    Cloning of Hordeum spontenaum genes which are expressed upon zinc deficiency using suppressed substractive hybridization methodKorkut SV, Altinisik BC, Sezerman OU, Meydan CCurrent Opinion in Biotechnology · DOI 10.1016/j.copbio.2011.05.398
47. 2010
    Multiple sequence alignment based on structural propertiesOzer B, Gezici G, Meydan C, Sezerman UHealth Informatics and Bioinformatics (HIBIT) · DOI 10.1109/hibit.2010.5478910
48. 2009
    Optimization of morphological data in numerical taxonomy analysis using genetic algorithms feature selection methodBakiş Y, Sezerman OU, Babaç MT, Meydan CGenetic and Evolutionary Computation Conference (GECCO) · DOI 10.1145/1570256.1570260
49. 2009
    Prediction of peptides binding to MHC class I alleles by partial periodic pattern miningMeydan C, Otu H, Sezerman UBioinformatics, Systems Biology and Intelligent Computing (IJCBS) · DOI 10.1109/ijcbs.2009.122First author
50. 2008
    Discovery of biomarkers for hexachlorobenzene toxicity using population based methods on gene expression dataMeydan C, Küçükural A, Yörükoğlu D, Sezerman OUPattern Recognition in Bioinformatics (PRIB) · DOI 10.1007/978-3-540-88436-1_35First author